![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmaceutical-technology.com/news/nmpa-zai-labs-repotrectinib/
https://endpts.com/ex-turning-point-execs-plan-to-have-their-next-bet-avenzo-on-the-nasdaq-next-summer/
https://endpts.com/bristol-myers-squibb-gets-necessary-clearance-for-4-1b-turning-point-acquisition/
https://www.globenewswire.com/news-release/2022/08/12/2497654/0/en/Turning-Point-of-Tampa-Opens-Drug-and-Alcohol-Detoxification-Program.html
https://www.globenewswire.com/news-release/2022/08/08/2494336/0/en/Turning-Point-Therapeutics-Reports-Second-Quarter-2022-Financial-Results-Provides-Operational-Updates.html
https://www.globenewswire.com/news-release/2022/07/27/2487265/0/en/Turning-Point-Therapeutics-Provides-Regulatory-Update-for-Repotrectinib-for-the-Treatment-of-ROS1-Advanced-NSCLC.html
https://www.globenewswire.com/news-release/2022/06/28/2470315/0/en/Petalfast-Partners-with-Turning-Point-Brands-to-Expand-Distribution-of-Zig-Zag.html
https://www.globenewswire.com/news-release/2022/06/24/2468792/0/en/Turning-Point-Therapeutics-and-MD-Anderson-Announce-Strategic-Alliance-to-Advance-Precision-Cancer-Therapies.html